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ABSTRACT
Headache is one of the most common neurological symptom occurring worldwide. Here, we present a unique case of secondary 
headache in a young female which got reversed with appropriate treatment. A young female who presented with a severe subacute 
unilateral left-sided intractable headache with papilledema and obstructive hydrocephalus was found to have 4th ventricular 
neurocysticercosis causing obstruction of the foramen of Magendi and Luschka, relieved on timely surgical excision and with medical 
management. This case is reported to highlight the rare causes of secondary headache and various presentations of neurocysticercosis, 
in endemic areas like India as it causes neurological morbidity which can be alleviated on appropriate treatment, thereby preventing 
economic hardship and improving the quality of life.
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Headache is a common neurological symptom presenting to neurology outpatient department. The headache is classified into two main groups: primary headache, 
which is the most common and secondary headache which is 
due to various etiologies such as intracranial mass lesions, giant 
cell arteritis, CNS infection etc [1]. Cysticercosis is one of the 
rare cause of secondary headache often encountered in endemic 
countries like India. Cysticercosis is a parasitic infection that 
results from ingestion of eggs of the adult pork tapeworm, Taenia 
solium (T. solium). Neurocysticercosis results from the hatching 
of larval forms in the digestive tract, which then penetrates the 
gut wall and spread via the bloodstream to encyst in the central 
nervous system (CNS). The resultant symptoms and pathology 
vary with the final resting site of the cysts in the CNS [2-4].
We present a rare cause of secondary headache in an endemic 
region of cysticercosis with the unusual manifestation of unilateral 
headache. The case highlights the need to exclude various causes 
of secondary headache so that early intervention and appropriate 
treatment cures it.
CASE REPORT
A 20-year-old female from a rural village of Tamil Nadu 
presented with a severe dull aching headache for the past 
one and half months which was predominantly left-sided, 
continuous associated with nausea and vomiting without any 
visual disturbances, postural imbalance, focal weakness, and 
seizures. There was no history of fever, nodular skin lesions, 
rash or multiple joint pain and loss of weight/appetite. No 
history of any co-morbid conditions. 
Figure 1: T1 contrast MRI Brain axial and coronal cut showing 
cystic lesion in 4th venticle with obstructive hydrocephalus.
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On examination, the patient was conscious oriented. Blood 
pressure was 130/80 mmHg, pulse rate was 82/minute and 
respiratory rate was 16/minute. Neurological examination 
revealed bilateral papilledema with an enlarged blind spot, 
however, rest neurological examinations were normal. Her other 
system examination was normal.
Routine blood examination including complete blood count, 
liver function test (LFT), renal function test (RFT) was normal.
On brain magnetic resonance imaging (MRI), there was a cyst 
with eccentric scolex in the 4th ventricle causing obstructive 
hydrocephalus (Fig. 1 and 2).
The patient was started on Albendazole 400mg BID with 
steroids. The patient underwent surgical excision of the cyst 
within a week. The cyst was approached through sub-occipital 
craniotomy through an incision extending from the external 
occipital protuberance to the spinous process of C7 cervical 
spine. Duramater was opened in a Y-shaped manner. The 
fourth ventricle was approached using a vermian split approach 
(Fig. 3). The cyst was a transparent structure of 2cm in size with a 
central nodule lying on the floor of the fourth ventricle.Complete 
excision of the cyst done in toto. After securing hemostasis,the 
closure was done in layers. On microscopic examination, the 
cyst showed scolex on H & E confirming active neurocysticerci 
(Fig. 4). The patient showed dramatic relief from headache 
after surgery and papilledema resolved within 2 weeks time. 
The patient is on follow-up and doing well with a resolution of 
symptoms and papilledema.
DISCUSSION
The lifetime prevalence of any type of headache as estimated 
from population-based studies is more than 90% for men and 
95% for women [5]. The extraparenchymal disease varies in 
its symptoms and prognosis according to the location of the 
parasites. The prognosis for intraventricular neurocysticercosis 
is worse than that for the intraparenchymal forms of the 
disease [6].
As a result of the mass effect, distortion of the normal 
anatomy of CSF pathways, direct obstruction of the ventricular 
system by a cyst, or an inflammatory reaction in the meninges 
leading to arachnoiditis, there will be an increase in intracranial 
CSF pressure. ln our patient, CSF obstruction due to a cyst in 
the 4th ventricle causing obstruction of the foramen of Magendi 
and Luschka resulting in obstructive hydrocephalus with dilated 
lateral and 3rd ventricle with increasing intracranial pressure 
producing a severe intractable headache. 
The various clinical presentations of the disease are due to 
the underlying different pathological processes which include 
space occupation, inflammation around the cyst, impaired 
cerebrospinal fluid flow, meningeal inflammation and vasculitis 
[7,8]. The most common presentation is a seizure (70–90% of 
patients) [9]. In 10%-20% of cases, symptoms are non-specific 
like nausea, vomiting, headache, ataxia, and confusion due to 
ventricular cysts. Hydrocephalus, vasculitis, and stroke can be a 
presentation of cysts of the basal cisterns. Rarer manifestations, 
like altered mental state, spinal cysticercosis with radicular 
Figure 4: Histopathology picture showing scolex with H & E stainFigure 2: T1 contrast sagittal cut showing neurocysticercosis in 4th 
ventricle.
Figure 3: Peroperative picture showing cyst in the 4th ventricle
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pain, paresthesia, progressive cord compression, ophthalmic 
cysticercosis, migraine headaches, neurocognitive deficits, and 
cerebral oedema are common in young girls [9]. The commonest 
pathological presentations are degenerating or calcified cyst 
(52%), followed by leptomeningitis (48%), which is most often 
basal and may cause hydrocephalus. In intraventricular forms, the 
4th ventricle is most frequently involved; the cyst may attach to 
the ventricular wall. 
A set of diagnostic criteria was proposed in 1996 and recently 
revisited to diagnose neurocysticercosis. Proper interpretation 
of these criteria permits two degrees of diagnostic certainty: 
definite or probable [10]. MRI is more accurate than computed 
tomography (CT) for the diagnosis of neurocysticercosis. In our 
case, MRI was used for the diagnosis of neurocysticercosis.
Treatment options include antihelminthic drugs (albendazole, 
praziquantel), surgery, and symptomatic medications. As 
inflammation is the conspicuous accompaniment in most forms 
of neurocysticercosis, corticosteroids are the mainstay in the 
treatment for cysticercal encephalitis, meningitis, and angiitis. 
The preferred drug is Albendazole which has got higher CSF 
penetration independent of steroid concentration [9,11].
Extra-parenchymal cysticercosis is associated with poor 
prognosis and requires a more aggressive approach. When 
feasible, complete surgical excision of lesions remains the 
definitive therapy [7,8]. The most common surgical indication 
for neurocysticercosis is ventricular neurocysticercosis causing 
obstructive hydrocephalus. Sometimes neurocysticercosis 
remains in the brain without causing any apparent symptoms; this 
form is called as asymptomatic neurocysticercosis [12,13]. 
CONCLUSION
Neurocysticercosis is a chronic parasitic disease that remains 
endemic in developing countries like India and has increasingly 
affecting developed countries also due to increased migration, 
tourism, and travel to endemic areas. This case has been presented 
to highlight the potentially treatable cause of subacute headache 
in a young female with neurocysticercosis. Appropriate measures 
like health education, mass awareness, deworming may help to 
reduce the disease burden in the endemic areas.
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